FDA
-
-
-
-
-
-
-
Nuwellis installs Aquadex SmartFlow systems in Wisconsin
-
-
-
-
-
-
-
Nuwellis completes FDA meeting for pediatric Aquadex label expansion
-
-
-
-
-
-
-
Nuwellis receives $3 million NIH grant for pediatric kidney device
-
-
-
-
-
-
-
Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care
-
-
-
-
-
-
-
SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner
-
-
-
-
-
-
-
New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid Overload
-
-
-
-
-
-
-
Nuwellis Provides Regulatory Update on SeaStar Medical’s Selective Cytopheretic Device Use in Pediatric Acute Kidney Injury Under a Humanitarian Device Exemption
-
329,981 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

